iotrolan has been researched along with Bronchiolitis Obliterans in 2 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Bronchiolitis Obliterans: Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morcos, SK | 1 |
| Anderson, PB | 1 |
| Morcas, SK | 1 |
2 other studies available for iotrolan and Bronchiolitis Obliterans
| Article | Year |
|---|---|
Bronchography with iotrolan 300.
Topics: Bronchial Diseases; Bronchiolitis Obliterans; Bronchography; Contrast Media; Humans; Tomography, X-R | 1995 |
The current state of lung transplantation.
Topics: Bronchiolitis Obliterans; Contrast Media; Humans; Lung Transplantation; Radiography; Triiodobenzoic | 1990 |